InterMune (nasdaq)ITMN Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : InterMune (nasdaq)ITMN

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Secret_Agent_Man who started this subject	4/26/2002 12:09:13 PM
From: IRWIN JAMES FRANKEL	Read Replies (1) of 508

A couple have asked about the NEJM study. Here is the ATS monograph in which the data was reviewed: intermune.com There were only 18 patients. I am not 100% sure that this is the 5 year survival data that is being presented at ATS next month but if it is not I am at a loss to understand the comment in the CC since I do not know of another NEJM publication on IPF. ij

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next